CAR-T Therapy in China for International Patients: The Complete Treatment Journey (2026)
Share
What actually happens, week by week, when a lymphoma patient travels to China for CAR-T therapy? Our CAR-T in China overview covers the science, the approved products and the landscape. This guide covers the part families ask about most: the journey itself — documents, timelines, the treatment weeks, and what it costs as a package.
Who this journey applies to
Commercial CD19 CAR-T in China is approved for adults with relapsed or refractory large B-cell lymphoma (r/r LBCL) after two or more lines of systemic therapy — including diffuse large B-cell lymphoma (DLBCL NOS), primary mediastinal large B-cell lymphoma, high-grade B-cell lymphoma, and DLBCL transformed from follicular lymphoma. In that heavily pre-treated setting, roughly a fifth of patients historically survived two years on older chemotherapy approaches — CAR-T changed that calculus, with pivotal trials reporting complete responses in a substantial fraction of patients.
(For gastric cancer CAR-T — a different therapy targeting CLDN18.2, approved only in China — see our dedicated eligibility guide.)
The journey at a glance
| Phase | Where | Duration |
|---|---|---|
| 1 · Records review & eligibility screening | From home (remote) | 1–2 weeks |
| 2 · Travel & baseline assessment | China | a few days |
| 3 · Cell collection (leukapheresis) | China | one session, 3–4 hours |
| 4 · Cell manufacturing | — | 2–3 weeks |
| 5 · Conditioning & infusion | China | 3 days + a 30-minute infusion |
| 6 · Inpatient monitoring | China | ≥10 days |
| 7 · Near-centre stay before flying home | China | ~4 weeks post-infusion |
Total time in China: plan for roughly 7–9 weeks, with a companion.
Phase 1 — Everything starts with your records, at home
Before anyone books a flight, the treatment centre screens your case remotely. What the team needs mirrors what any CAR-T-certified centre would ask:
- Pathology report confirming the lymphoma subtype
- Complete treatment history — regimens, cycles, response assessments
- Recent imaging (PET-CT is ideal; see our guide to PET-CT in lymphoma)
- Recent blood work and organ function
- Performance status and current symptoms
We translate documents where needed and return a written eligibility opinion. If the answer is no — because of disease biology, fitness, or because a better option exists at home — you hear that plainly, with reasons. This is the case-review service that handles it.
Phase 2 — Travel, without visa drama
For treatment programmes of this length you will need an appropriate visa; the hospital issues a visa invitation letter supporting your application, and our team walks you through the process for your nationality. (Shorter consultations and screenings often fit China's 30-day visa-free entry, but a CAR-T stay is longer — plan on a proper visa.)
On arrival: airport pick-up, hospital registration, interpreter introduction, and baseline assessments to confirm nothing has changed since screening.
Phase 3 — Cell collection day
Leukapheresis feels like an extended blood donation: blood is drawn from one arm, a machine separates out the T-cells, and the rest returns through the other arm. It takes 3–4 hours, awake and comfortable. Your cells are then couriered to the manufacturer.
Phase 4 — The manufacturing wait (2–3 weeks)
Your T-cells are genetically engineered to carry a chimeric antigen receptor (CAR) recognising CD19, expanded to therapeutic numbers, and quality-checked. Families use this window differently: some stay and explore the Greater Bay Area gently; the medical team advises what activity level makes sense. Your coordinator handles accommodation — long-stay options near the hospital, halal meals arranged where needed.
Phase 5 — Conditioning and the infusion itself
Three days of preparatory (lymphodepleting) treatment ready your immune system to receive the engineered cells. Then the moment the whole journey builds to is — deliberately — undramatic: a single infusion of about 30 minutes.
Phase 6 — The monitoring window: why you stay close
The first two weeks after infusion are when known side effects appear, and why CAR-T only happens at certified centres:
- Cytokine release syndrome (CRS) — fever, low blood pressure, rapid heart rate as the engineered cells activate. Common, graded, and managed by teams trained specifically for it.
- Neurological events — confusion or speech difficulty, usually temporary, monitored daily.
- Low blood counts, infection risk, fatigue.
You are an inpatient for at least 10 days, then remain within reach of the centre until about 4 weeks post-infusion. Report any fever or feeling unwell immediately — early management is what makes these effects controllable.
Phase 7 — Flying home, and what follows
Before departure you receive a translated discharge package: treatment summary, infusion details, complication log, blood trends and a follow-up schedule your home haematologist can act on — including monitoring for low immunoglobulin levels and infection risk during B-cell recovery. Response assessment happens on imaging over the following months at home, with remote review available.
What it costs — as a package, in writing
At our partner hospital network, a lymphoma CAR-T programme is quoted as an all-inclusive package estimated around RMB 1.32 million (≈ US$207,000), covering the commercial CAR-T cell product itself, apheresis, conditioning, the infusion, roughly 25 nights of hospitalisation with monitoring, ward accommodation, nursing, interpreter support, translated documentation and airport transfers. Complication management beyond the defined package, extended stays, and unrelated therapies are quoted separately — in writing, before they happen. How our all-inclusive pricing works →
Context: in the US, list prices for the CAR-T product alone are commonly around US$400,000+, before hospitalisation. In many countries with approved access, the practical constraints are eligibility windows and scheduling rather than headline price. Families choose China variously for cost, for timing, or because a specific therapy isn't available at home — the written opinion helps you weigh which applies to you.
Practical checklist for families
- Bring a companion — the package includes a companion bed; this is a two-person journey.
- Budget 7–9 weeks in China, plus screening time before travel.
- Gather the five document types before asking for screening — it converts a vague enquiry into a fast, definite answer.
- Keep your home haematologist involved from day one; the goal is a seamless handover in both directions.
- Ask us the uncomfortable questions — response rates for your subtype, what happens if CRS is severe, what the package excludes. Written answers, before commitment.
Request an eligibility review Explore the full oncology programme